UNC and UNC Hospitals were recently selected as a Regional Emerging Special Pathogen Treatment Center (RESPTC) by the U.S. Department of Health and Human Services' Administration for Strategic Preparedness and Response. RESPTCs are special care units that treat serious, highly communicable infectious diseases such as ebola or monkeypox. (Daily Tar Heel)
Related: Campus Connections
UNC professor receives inaugural award for pioneering gene therapy
The European Society of Gene and Cell Therapy Founders Award was given to Jude Samulski, professor in the University of North Carolina School of Medicine’s.